Diabetes, Obesity and Metabolism Diabetes, Obesity and Metabolism RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Adjusting insulin doses in patients with type 1 diabetes that use insulin pump and continuous glucose monitoring ‐ Variations among countries and physicians
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 9, 2018 Category: Endocrinology Authors: Revital Nimri M.D , Eyal Dassau Ph.D , Tomer Segall B.Sc , Ido Muller B.Sc , Natasa Bratina M.D , Olga Kordonouri M.D , Rachel Bello M.D , Torben Biester M.D , Klemen Dovc M.D , Ariel Tenenbaum M.D , Avivit Brene Source Type: research

Obese individuals with type 2 diabetes demonstrate decreased activation of the salience ‐related insula and increased activation of the emotion/salience‐related amygdala to visual food cues compared to non‐obese individuals with diabetes: a preliminary study
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 8, 2018 Category: Endocrinology Authors: Olivia M. Farr PhD , Christos S. Mantzoros MD DSc PhD h.c.mult Source Type: research

Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1 ‐5 trials
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 8, 2018 Category: Endocrinology Authors: Mark Warren MD , Louis Chaykin MD , David Trachtenbarg MD , Gurudutt Nayak MD , Nelun Wijayasinghe MD , Bertrand Cariou MD Source Type: research

Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 8, 2018 Category: Endocrinology Authors: Peter Breining , Jonas B. Jensen , Elias I. Sundelin , Lars C. Gormsen , Steen Jakobsen , Morten Busk , Lars Rolighed , Peter Bross , Paula Fernandez ‐Guerra , Lasse K. Markussen , Nanna E. Rasmussen , Jacob B Source Type: research

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in db/db mice: The earlier and longer, the better
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Tomohiko Kimura , Atsushi Obata , Masashi Shimoda , Seizo Okauchi , Yukiko Kanda ‐Kimura , Yuka Nogami , Saeko Moriuchi , Hidenori Hirukawa , Kenji Kohara , Shuhei Nakanishi , Tomoatsu Mune , Kohei Kaku , Source Type: research

Corrigendum
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Source Type: research

This is in reply to the Letter by Kahathuduwa et al. titled “Unaccounted for regression to the mean renders conclusion of article titled ‘Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin’ unsubstantiated”
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Motoshi Ouchi MD , Kenzo Oba MD , Hideki Suganami PhD , Akihiro Yoshida , Tomoe Fujita MD , Tatsuya Suzuki MD , Masahiro Yasutake MD , Kohei Kaku MD Source Type: research

European Medicines Agency: Approval of new glucose ‐lowering medicines for type 2 diabetes
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Clifford J. Bailey PhD Source Type: research

Efficacy and safety of MK ‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Philip D. Home DPhil , Raymond L. H. Lam PhD , Wendy L. Carofano PharmD , Gregory T. Golm PhD , Roy Eldor MD , Michael F. Crutchlow MD , Michael C. Marcos MS , Julio Rosenstock MD , Priscilla A. Hollander MD , Baptis Source Type: research

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Helen J. Curtis , John M. Dennis , Beverley M. Shields , Alex J. Walker , Seb Bacon , Andrew T. Hattersley , Angus G. Jones , Ben Goldacre Source Type: research

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East ‐Asian patients with type 2 diabetes in a multicentre, double‐blind, randomized, parallel‐arm, active comparator, phase III trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Yu Hong Chen MD , Chien ‐Ning Huang MD , Young Min Cho MD , Pengfei Li PhD , Liqun Gu MD , Feng Wang MD , Jun Yang MD , Wei Qing Wang MD Source Type: research

Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 5, 2018 Category: Endocrinology Authors: Ji H. Han PhD , Hanho Shin , Jun G. Rho , Jung ‐Eun Kim , Dong H. Son , Juhwan Yoon , Yong J. Lee PhD , Jung‐Hyuck Park , Byung J. Song PhD , Chang‐Sik Choi , Seul G. Yoon , Il Y. Kim PhD , Eun K. Lee Source Type: research

Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4 ‐week, double‐blind, randomized, placebo‐controlled phase 2 trial
Diabetes, Obesity and Metabolism, EarlyView. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 5, 2018 Category: Endocrinology Authors: Akira Shimada MD , Toshiaki Hanafusa MD , Atsutaka Yasui PhD , Ganghyuck Lee MSc , Yusuke Taneda MSc , Akiko Sarashina MSc , Kosuke Shiki MSc , Jyothis George MD , Nima Soleymanlou PhD , Jan Marquard MD Source Type: research

Glycemic Control In The Diabetes And Lifestyle Cohort Twente ‐ A Cross‐Sectional Assessment Of Lifestyle And Pharmacological Management On Hba1c Target Achievement
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 4, 2018 Category: Endocrinology Authors: Annis C. Jalving , Christina M. Gant , S. Heleen Binnenmars , Sabita S. Soedamah ‐Muthu , Stephan J.L. Bakker , Gerjan Navis , Gozewijn D. Laverman Source Type: research

Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-. (Source: Diabetes, Obesity and Metabolism)
Source: Diabetes, Obesity and Metabolism - June 4, 2018 Category: Endocrinology Authors: Jingyi Qian , Chiara Dalla Man , Christopher J. Morris , Claudio Cobelli , Frank AJL Scheer Source Type: research